Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

PUBLICATION DATE

1 results
Display

Sclerotherapy with OK-432 for recurrent cystic thyroid nodule

Chang HS, Yoon JH, Chung WY, Park CS

We have adopted OK-432 as a sclerosing agent in the treatment of cystic predominant thyroid nodules and have analyzed our findings to assess the efficacy of intralesional instillation of OK-432....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr